Duloxetine versus citalopram and sertraline in the treatment of poststroke depression, anxiety, and fatigue.

@article{Karaiskos2012DuloxetineVC,
  title={Duloxetine versus citalopram and sertraline in the treatment of poststroke depression, anxiety, and fatigue.},
  author={Dimitrios C. Karaiskos and Elias Odusseas Tzavellas and Konstantinos M Spengos and Sofia D. Vassilopoulou and Thomas Paparrigopoulos},
  journal={The Journal of neuropsychiatry and clinical neurosciences},
  year={2012},
  volume={24 3},
  pages={349-53}
}
The authors sought to determine the relative efficacy and tolerability of duloxetine versus citalopram and sertraline in the treatment of poststroke depression (PSD), anxiety, and fatigue. A group of 60 patients with PSD were assigned to receive duloxetine, citalopram, or sertraline and were assessed over a 3-month period for depression, anxiety, and fatigue. Improvement of depression and anxiety, but not fatigue, was observed in all study groups. Duloxetine was well tolerated and significantly… CONTINUE READING

3 Figures & Tables

Connections & Topics

Mentioned Connections BETA
Duloxetine versus citalopram and sertraline in the treatment of poststroke depression , anxiety , and fatigue .
Duloxetine was well tolerated and significantly more effective than citalopram and sertraline for the treatment of anxiety symptoms in PSD patients .
A group of 60 patients with PSD were assigned to receive duloxetine , citalopram , or sertraline and were assessed over a 3-month period for depression , anxiety , and fatigue .
The authors sought to determine the relative efficacy and tolerability of duloxetine versus citalopram and sertraline in the treatment of poststroke depression ( PSD ) , anxiety , and fatigue .
Duloxetine versus citalopram and sertraline in the treatment of poststroke depression , anxiety , and fatigue .
The authors sought to determine the relative efficacy and tolerability of duloxetine versus citalopram and sertraline in the treatment of poststroke depression ( PSD ) , anxiety , and fatigue .
A group of 60 patients with PSD were assigned to receive duloxetine , citalopram , or sertraline and were assessed over a 3-month period for depression , anxiety , and fatigue .
Duloxetine was well tolerated and significantly more effective than citalopram and sertraline for the treatment of anxiety symptoms in PSD patients .
Duloxetine versus citalopram and sertraline in the treatment of poststroke depression , anxiety , and fatigue .
Duloxetine was well tolerated and significantly more effective than citalopram and sertraline for the treatment of anxiety symptoms in PSD patients .
A group of 60 patients with PSD were assigned to receive duloxetine , citalopram , or sertraline and were assessed over a 3-month period for depression , anxiety , and fatigue .
The authors sought to determine the relative efficacy and tolerability of duloxetine versus citalopram and sertraline in the treatment of poststroke depression ( PSD ) , anxiety , and fatigue .
The authors sought to determine the relative efficacy and tolerability of duloxetine versus citalopram and sertraline in the treatment of poststroke depression ( PSD ) , anxiety , and fatigue .
Duloxetine versus citalopram and sertraline in the treatment of poststroke depression , anxiety , and fatigue .
Duloxetine was well tolerated and significantly more effective than citalopram and sertraline for the treatment of anxiety symptoms in PSD patients .
A group of 60 patients with PSD were assigned to receive duloxetine , citalopram , or sertraline and were assessed over a 3-month period for depression , anxiety , and fatigue .
Duloxetine versus citalopram and sertraline in the treatment of poststroke depression , anxiety , and fatigue .
The authors sought to determine the relative efficacy and tolerability of duloxetine versus citalopram and sertraline in the treatment of poststroke depression ( PSD ) , anxiety , and fatigue .
A group of 60 patients with PSD were assigned to receive duloxetine , citalopram , or sertraline and were assessed over a 3-month period for depression , anxiety , and fatigue .
Duloxetine versus citalopram and sertraline in the treatment of poststroke depression , anxiety , and fatigue .
The authors sought to determine the relative efficacy and tolerability of duloxetine versus citalopram and sertraline in the treatment of poststroke depression ( PSD ) , anxiety , and fatigue .
A group of 60 patients with PSD were assigned to receive duloxetine , citalopram , or sertraline and were assessed over a 3-month period for depression , anxiety , and fatigue .
Duloxetine versus citalopram and sertraline in the treatment of poststroke depression , anxiety , and fatigue .
The authors sought to determine the relative efficacy and tolerability of duloxetine versus citalopram and sertraline in the treatment of poststroke depression ( PSD ) , anxiety , and fatigue .
A group of 60 patients with PSD were assigned to receive duloxetine , citalopram , or sertraline and were assessed over a 3-month period for depression , anxiety , and fatigue .
Duloxetine was well tolerated and significantly more effective than citalopram and sertraline for the treatment of anxiety symptoms in PSD patients .
The authors sought to determine the relative efficacy and tolerability of duloxetine versus citalopram and sertraline in the treatment of poststroke depression ( PSD ) , anxiety , and fatigue .
Duloxetine versus citalopram and sertraline in the treatment of poststroke depression , anxiety , and fatigue .
Duloxetine was well tolerated and significantly more effective than citalopram and sertraline for the treatment of anxiety symptoms in PSD patients .
A group of 60 patients with PSD were assigned to receive duloxetine , citalopram , or sertraline and were assessed over a 3-month period for depression , anxiety , and fatigue .
All Topics